Number of Shares
45,900.00
Current Holdings Value*
$1.02 Mil
% of Portfolio
6.5%
Total Estimate Gain
$1.18 Mil
% of Total Estimate Gain
9.48%

Lion Point Capital, LP's Kiniksa Pharmaceuticals International PLC Holding Summary

As of 2025-03-31, Lion Point Capital, LP held 45,900.00 shares of Kiniksa Pharmaceuticals International PLC(KNSA), totaling $1.02 Mil. This investment constitutes 6.5% of their stock portfolio, and Lion Point Capital, LP now holds 0.06% of the outstanding Kiniksa Pharmaceuticals International PLC(KNSA) stock.

The initial trade took place in 2020Q1. And since then Lion Point Capital, LP has made 3 purchases of KNSA, at an average price of $13.30, for a total of 937,899.00 shares. In addition, there have been 6 sales at an average price of $13.83 for 891,999.00 shares. Based on historical transaction data and KNSA's current price of $28.80, Lion Point Capital, LP's estimated gain on his KNSA holdings is $1.18 Mil, reflecting a 9.48% gain to date.

Lion Point Capital, LP KNSA ($28.80) Holding Chart

Lion Point Capital, LP KNSA ($28.80) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1